Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
The investigators aim to start a prospective and observational study over a 2 years period.
First, the investigators will identify all children suffering from cirrhosis irrespective of underlying etiology and/or portal hypertension coming into the pediatric hepatogastroenterology unit at Saint-Luc University Clinics. Any patient with a congenital or acquired thrombophilia/haemorrhagic disorder will be excluded. The investigators expect to include 20 to 30 children in the study.
The investigators will meet the parents to give them explanations about this study and its implications. Then the investigators will get the free and informed consent about the participation to this clinical study. Parents are obviously free to refuse to take part in this clinical study and to retire from it at any moment.
Age
0–50
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Children suffering from decompensated cirrhosis and needing an orthotopic liver transplantation
Children suffering from a compensated cirrhosis (compensated cirrhosis with kasai surgery in biliary atresia patients e.g) or from portal hypertension without cirrhosis (portal vein thrombosis e.g)
Each patient will have a comprehensive assessment of portal hypertension (abdominal US-Doppler and upper gastrointestinal endoscopy) and hemostasis
You may not be if
No underlying disease which can alter hemostasis (hemophilia, sepsis…)
No medication which can alter hemostasis (aspirin, anti-inflammatory drugs,…)
Clareo Health | HEMOCC Study. Hemostasis in Cirrhotic Children.
